Back to Search
Start Over
Abicipar pegol-a novel anti-VEGF therapy with a long duration of action.
- Source :
-
Eye (London, England) [Eye (Lond)] 2020 Apr; Vol. 34 (4), pp. 605-606. Date of Electronic Publication: 2019 Sep 19. - Publication Year :
- 2020
- Subjects :
- Bevacizumab
Humans
Recombinant Fusion Proteins
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5454
- Volume :
- 34
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Eye (London, England)
- Publication Type :
- Editorial & Opinion
- Accession number :
- 31537893
- Full Text :
- https://doi.org/10.1038/s41433-019-0584-y